Topic: artificial intelligence
Precision oncology firm Notable Labs is launching its first self-sponsored clinical trial, designed from the ground up to help validate its platform.
As GlaxoSmithKline looks to start a 23andMe-partnered test this year, the Big Pharma is increasingly looking to tech for its R&D.
Concerto HealthAI unveiled a steady drum beat of announcements at this year’s J.P. Morgan Healthcare Conference, including a $150 million raise.
TransEnterix has put up its machine vision system for review by the FDA with the goal of providing surgeons a personal digital assistant.
Nference thinks its platform can help identify new targets and drug combinations by corralling existing data.
Canadian drug development company Deep Genomics has got off a $40 million ound as it looks to double down on its rare genetic disease and AI work.
Google’s DeepMind AI team showed that it can outperform trained radiologists in spotting cases of breast cancer.
Oxford, U.K.-based clinical trial artificial intelligence tech company Sensyne Health has signed a new research project deal with Swiss major Roch
As a part of its new digital orthopedic surgery platform, Johnson & Johnson’s DePuy Synthes division will work with Zebra Medical Vision.
As we close out the decade, our biggest medtech stories have all looked toward what’s coming next—whether it’s new treatments or renewed companies.